
BIRM 271
CAS No. 149106-77-4
BIRM 271 ( —— )
产品货号. M37008 CAS No. 149106-77-4
BIRM 271 is a novel arachidonic acid release inhibitor that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils. BIRM 271 and BIRM 270 are enantiomers that inhibit the production of leukotriene B4 with IC50 of 40 nM.
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥2519 | 有现货 |
![]() ![]() |
5MG | ¥3472 | 有现货 |
![]() ![]() |
10MG | ¥5136 | 有现货 |
![]() ![]() |
25MG | ¥7718 | 有现货 |
![]() ![]() |
50MG | ¥10635 | 有现货 |
![]() ![]() |
100MG | ¥14000 | 有现货 |
![]() ![]() |
500MG | ¥28152 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称BIRM 271
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述BIRM 271 is a novel arachidonic acid release inhibitor that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils. BIRM 271 and BIRM 270 are enantiomers that inhibit the production of leukotriene B4 with IC50 of 40 nM.
-
产品描述BIRM 271 is a novel arachidonic acid release inhibitor that blocks leukotriene B4 and platelet-activating factor biosynthesis in human neutrophils. BIRM 271 and BIRM 270 are enantiomers that inhibit the production of leukotriene B4 with IC50 of 40 nM.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Metabolic Enzyme/Protease
-
靶点Phospholipase
-
受体Phospholipase | LTR
-
研究领域——
-
适应症——
化学信息
-
CAS Number149106-77-4
-
分子量335.44
-
分子式C21H25N3O
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESN([C@H](CC1CCCCC1)C2=CC=CC=N2)C=3OC=4C(N3)=CC(C)=CC4
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册




关联产品
-
Lp-PLA2-IN-3
Lp-PLA2-IN-3 是一种有效的、口服的脂蛋白相关磷脂酶 A2 (Lp-PLA2) 抑制剂,对重组人 Lp-PLA2 (Lp-PLA2) 的IC50 为14 nM。
-
VU0155069
VU0155069 (CAY10593),化合物 69 是一种选择性磷脂酶 D1 (PLD1) 抑制剂,IC50 值为 46 nM。VU0155069 (CAY10593) 在 transwell 测定中强烈抑制几种癌细胞系的侵袭性迁移。
-
PACOCF3
PACOCF3 (Palmityltrifluoromethylketone) 是一种选择性磷脂酶 A2 (phospholipase A2) 抑制剂,IC50 为 3.8 μM。PACOCF3 改变肾小管细胞中的 Ca2+ 信号传导。